Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Looks To Capitol Hill For New Authority For Globalization Plan

This article was originally published in The Pink Sheet Daily

Executive Summary

The agency still plans to move forward with coalition-building and increased data-sharing aspects of globalization initiative.
Advertisement

Related Content

FDA Envisions Many Regulatory Coalitions Dealing With Globalization Issues
Lilly's Field Of Dreams: "Campaign For Modern Medicines" Wants A Clean PDUFA
Inspection Improvements Could Help Fight Drug Shortages, Hospital Group Says
GMP Oversight Collaboration Helps FDA Plan, But Not Avoid, Foreign Inspections
Global GMPs: How Much Faith Will FDA Put In Private Third-Party Audits?
What’s In A PDUFA Reauthorization? Maybe These Issues…
Not Another FDAAA – Observers Expect Fewer FDA Reforms In PDUFA V
FDA Foreign Inspections User Fee Program Getting Push On The Hill
"Mega-UFA" Is Behind Schedule; Combined User Fee Bill Will Be Difficult, But Still Expected
"Mega-UFA" Is Behind Schedule; Combined User Fee Bill Will Be Difficult, But Still Expected

Topics

Advertisement
UsernamePublicRestriction

Register

PS072391

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel